Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic

Y Fan1, L M Shi, K W Kohn

  • 1Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

This study developed a quantitative structure-activity relationship (QSAR) model for topoisomerase 1 inhibitors using NCI drug data. The model identifies key molecular features correlating with antitumor activity, aiding in the design of novel cancer therapeutics.

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Oncology

Background:

  • Topoisomerase 1 (Top1) inhibitors are crucial for treating refractory tumors, yet their binding site and activity-driving ligand properties remain poorly understood.
  • Developing new Top1 agents is of significant interest, necessitating a deeper understanding of structure-activity relationships.

Purpose of the Study:

  • To establish a quantitative structure-activity relationship (QSAR) model for camptothecins (CPTs) using National Cancer Institute (NCI) drug databases.
  • To identify molecular descriptors correlating with antitumor activity for improved drug design.

Main Methods:

  • Utilized hierarchical clustering to analyze antitumor activity patterns of 167 CPTs from the NCI drug database.
  • Applied various statistical methods, including genetic function approximation (GFA), to build QSAR models.
  • Identified key molecular descriptors, including partial atomic charges and specific interatomic distances, correlated with antitumor activity.

Main Results:

  • Observed coherence between CPT chemical structures and their antitumor activity patterns (average Pearson correlation coefficient of 0.70).
  • The GFA method demonstrated superior performance in correlation and cross-validation compared to other statistical approaches.
  • A predictive QSAR model was developed with a cross-validated r² of 0.783.

Conclusions:

  • The developed QSAR model provides valuable insights into the structural determinants of Top1 inhibitor activity.
  • This approach aids in understanding drug action and resistance mechanisms.
  • The identified molecular descriptors can guide the rational design of novel and more effective Top1-based anticancer drugs.